Benzinga's Top Upgrades

Stifel Nicolaus upgraded St. Jude Medical (NYSE: STJ ) from “hold” to “buy.” The price target for St. Jude Medical is set to $75. St. Jude Medical's shares closed at $62.00 on Friday. Analysts at Keefe Bruyette & Woods upgraded Legg Mason (NYSE: LM ) from “market perform” to